This topic contains a solution. Click here to go to the answer

Author Question: A nurse is caring for a client with urinary retention who is receiving a cholinergic drug as part of ... (Read 47 times)

crazycityslicker

  • Hero Member
  • *****
  • Posts: 537
A nurse is caring for a client with urinary retention who is receiving a cholinergic drug as part of the treatment plan. After administering the drug, the nurse would notify the primary health care provider
 
  if the assessment reveals which of the following?
 
  A) Failure to void after drug administration
  B) Frequent vomiting after drug administration
  C) Increase in abdominal pain after drug administration
  D) Occurrence of blood in urine after drug administration

Question 2

A nurse is caring for a client with urinary retention who is prescribed bethanechol. The nurse would administer this drug cautiously if the client has which of the following?
 
  A) Raynaud's disease
  B) Bradycardia
  C) Coronary artery disease
  D) Hyperthyroidism



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

swimkari

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

Ans: A
Feedback:
The nurse should notify the primary health care provider if the client fails to void after drug administration. Frequent vomiting, increase in abdominal pain, and occurrence of blood in urine are not usually observed when urinary retention is treated with cholinergic therapy.

Answer to Question 2

Ans: B
Feedback:
The nurse should administer bethanechol cautiously if a client has bradycardia, hypertension, epilepsy, cardiac arrhythmias, recent coronary occlusion, or megacolon. Cautious use is not necessary if the client has Raynaud's disease, coronary artery disease, or hyperthyroidism.




crazycityslicker

  • Member
  • Posts: 537
Reply 2 on: Jul 23, 2018
Gracias!


bitingbit

  • Member
  • Posts: 323
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

For a complete list of videos, visit our video library